Cargando…
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused more than 96 million infections and over 2 million deaths worldwide so far. However, there is no approved vaccine available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the disease causative agent. Vaccine is the mo...
Autores principales: | Yao, Yan-Feng, Wang, Ze-Jun, Jiang, Ren-Di, Hu, Xue, Zhang, Hua-Jun, Zhou, Yi-Wu, Gao, Ge, Chen, Ying, Peng, Yun, Liu, Mei-Qin, Zhang, Ya-Nan, Min, Juan, Lu, Jia, Gao, Xiao-Xiao, Guo, Jing, Peng, Cheng, Shen, Xu-Rui, Li, Qian, Zhao, Kai, Yang, Lian, Wan, Xin, Zhang, Bo, Wang, Wen-Hui, Wu, Jia, Zhou, Peng, Yang, Xing-Lou, Shen, Shuo, Shan, Chao, Yuan, Zhi-Ming, Shi, Zheng-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034048/ https://www.ncbi.nlm.nih.gov/pubmed/33835391 http://dx.doi.org/10.1007/s12250-021-00376-w |
Ejemplares similares
-
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models
por: Wang, Ze-Jun, et al.
Publicado: (2020) -
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate
por: Zhang, Xiao-Yu, et al.
Publicado: (2020) -
Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
por: He, Qian, et al.
Publicado: (2022) -
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques
por: Shan, Chao, et al.
Publicado: (2020) -
Essential roles of leucine-rich glioma inactivated 1 in the development of embryonic and postnatal cerebellum
por: Xie, Ya-Jun, et al.
Publicado: (2015)